Clinical trial
Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)
NCT03178643 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 23, 2018
- Completion date
- December 16, 2020
- Enrollment
- 246 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malaria,falciparum